Feed 6108.HK
61
New Ray Medicine International Holding Ltd.
6108.HK · HKSE
$0.22 +3.26% (+$0.01)
1M +6.97%
Valuation
-
N/A P/E N/A
EV/EBITDA N/A
P/S N/A
Growth
-
N/A EPS growth N/A
Rev. growth N/A
FCF growth N/A
Profitability
-
N/A Gross margin N/A
Net margin N/A
Op. margin N/A
Quality
-
N/A ROIC N/A
ROE N/A
ROA N/A
Debt
-
N/A Debt/Equity N/A
Current ratio N/A
Int. coverage N/A
Stability
50 /100
Moderate Beta -3.94x
Rev. volatility N/A
EPS volatility N/A
Vprašajte StockBota o 6108.HK
Online
Sector
Healthcare
Industry
Medical - Pharmaceuticals
CEO
Qiuqin Wang
Employees
31
Headquarters
Hangzhou
Prihajajoči dogodki
31 AVG.
Earnings
Upcoming earnings report